Please login to the form below
priority access
This page shows the latest priority access news and features for those working in and with pharma, biotech and healthcare.
Biopharma industry launches Berlin Declaration to ensure equal access during future pandemics
Budi Gunadi Sadikin, minister of health for Indonesia, said: “I welcome the biopharmaceutical industry’s commitment to our shared vision for ‘real-time’ access to priority populations in lower income countries. ... Achieving more equitable access
Latest news
-
EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
Bavarian Nordic has announced that the European Medicines Agency (EMA) has granted access to its priority (PRIME) scheme for the company's vaccine candidate for the prevention of lower respiratory tract ... There is currently no approved vaccine for RSV
-
Biogen’s Alzheimer’s treatment Aduhelm limited to clinical trial participants in the US
However, regulators said at the time that the top priority was to provide patients with access to a potentially life-changing drug. ... Biogen added that the limited coverage ‘will significantly limit patient access to an FDA-approved treatment,
-
WHO advises both doses of Pfizer/BioNTech’s COVID-19 vaccine within a 21-28 day schedule
The WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) added, however, that countries should be able to administer the two doses over six weeks to ensure more high-priority ... groups can access the vaccine.
-
Abivax’s COVID-19 study declared Research National Priority by French government
Those clinical trials, including Abivax’s study, that are declared to be a national priority gain access to an accelerated regulatory review and approval process by the French regulatory authorities (ASNM) ... AGE trial with ABX464 drug candidate a
-
WHO says 172 countries are poised to participate in COVID-19 vaccine initiative
It is the only global initiative working with governments and manufacturers to ensure equitable access to COVID-19 vaccines. ... vulnerability, with front-line health and social care workers to be given priority.
More from news
Approximately 1 fully matching, plus 18 partially matching documents found.
Latest Intelligence
-
‘Who moved my cheese?’
Knowing your audience will help you get the ‘cheese’. Second, creating clear, simple and engaging messaging that audiences can easily access should become a priority.
-
Building BRICs: pharma's key emerging markets are becoming giants
Further, the inference that locally-produced drugs may gain preferential access to state reimbursement lists has provided an added incentive for international manufacturers to invest in Russian infrastructure. ... Improving access to healthcare remains a
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- bluebird bio reveals plans to launch two gene therapies
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- Eli Lilly to make bebtelovimab commercially available to US states from August
- Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
- The patient voice – the value of patient-reported outcomes in HTA
- Biogen and Eisai share latest lecanemab results for the treatment of Alzheimer's disease
- Strategic commitment
- Pfizer set to acquire Global Blood Therapeutics in deal worth $5.4bn
- AstraZeneca and Daiichi Sankyo get FDA approval for breast cancer drug
- NHS England launches hepatitis C screening scheme to reach 2030 elimination goal
- Bayer’s Nubeqa receives FDA approval to treat metastatic prostate cancer
- Valneva and Pfizer initiate phase 3 Lyme disease vaccine study
- GSK’s ViiV and Medicines Patent Pool agree deal for HIV prevention
- GSK/Merck KGgA cancer drug fails in third trial
- Chiesi Group's Trimbow wins European licence
- Roche shares new positive Ocrevus data for MS patients
- Roche’s Tecentriq demonstrates positive phase 3 results as a subcutaneous injection
- Using behavioural psychology to improve patient recruitment
PMHub
JPA Health
JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...
Latest intelligence
- Strategic commitment
- ...
- KOL Ambassador Program & Podcast Creation: A Customer Story
- ...
- Animation: Living With
- The journey from the patient's perspective...
